openPR Logo
Press release

Intracellular Targets Made Druggable by TCR-like Antibodies and Cell-Penetrating Biologics 2018; New Report Launched

Intracellular Targets made druggable by TCR-like Antibodies, TCR Fusion Proteins & Cell-Penetrating Biologics 2018

Intracellular Targets made druggable by TCR-like Antibodies, TCR Fusion Proteins & Cell-Penetrating Biologics 2018

Market Research Reports, Inc. has announced the addition of “Intracellular Targets made druggable by TCR-like Antibodies, TCR Fusion Proteins & Cell-Penetrating Biologics 2018: an industry analysis of technologies, stakeholders, deals & trends” research report to their offering.

Intracellular Targets made druggable by TCR-like Antibodies, TCR Fusion Proteins & Cell-Penetrating Biologics 2018: an industry analysis of technologies, stakeholders, deals & trends

It is estimated that there are 3-4 times more intracellular targets than surface protein targets. However, these intracellular cancer targets are not accessible to traditional monoclonal antibody (mAb) therapies. Since many of these targets are not enzymes or surface receptoers with readily druggable pockets, these important oncogenic proteins cannot be easily inhibited with small molecules. Thus, intracellular cancer-specific proteins, such as mutated oncogene products, transcription factors, protein adapters, and other nontraditional targets, remain inaccessible to current technologies used for FDA-approved drugs.

Therefore, novel technologies are needed to address historically undruggable targets and complex mechanisms, such as intracellular protein-protein interactions like p53 or Ras, β-catenin and Myc.

This report „Intracellular Targets made druggable by TCR-like Antibodies, TCR Fusion Proteins & Cell-Penetrating Biologics 2018: an industry analysis of technologies, stakeholders, deals & trends“ brings you up-to-date regarding key technologies
- for identification and validation of intracellular targets,
- for generation of T-cell receptors (TCR) and TCR fusion proteins,
- for discovery of TCR-like antibodies, and
- for construction of cell-penetrating peptides, proteins and antibodies.

The report furthermore describes the profiles of leading product candidates created by these technologies. The technology companies are presented and analyzed. Deals between Big Pharma and technology companies as well as collaboration and licensing deals between technology companies are highlighted. The value of technologies and product candidates are discussed regarding company acquisition prices, economic deal terms and financing rounds.

What will you find in the report?
Description and comparison of technologies for
- Discovery and validation of intracellular targets;
- Discovery and optimization of T-Cell Receptors (TCRs);
- Generation of TCR-like or TCR-mimic antibodies;
- Generation of TCR fusion proteins
- Generation of cell-penetrating peptides, proteins and antibodies.

Presentation and discussion of profiles of selected product candidates:
- TCRL antibodies and TCR fusion proteins; and
- Cell-penetrating peptides, miniproteins and single domain and Ig antibodies

Spanning over 252 pages “Intracellular Targets made druggable by TCR-like Antibodies, TCR Fusion Proteins & Cell-Penetrating Biologics 2018: an industry analysis of technologies, stakeholders, deals & trends” report covers Executive Summary, Introduction & Overview, Background, Technology Profiles, Overview & Discussion, Technologies for Discovery of Intracellular Targets, Pipeline Analysis and Product Profiles, Stakeholder Analysis & Company Profiles, Deals & Financing, Trends & Outlook, References. This report Covered Companies few are - AstraZeneca, Atreca, BioNTech, Boehringer Ingelheim, Complix, Elasmogen, Eli Lilly, Eureka Therapeutics, Feldan Therapeutics, Fog Pharmaceuticals, Gadeta, Gilead Sciences (Kite Pharma), GlaxoSmith-Kline, Immatics Biotechnologies.

Please visit this link for more details: https://www.marketresearchreports.com/la-merie-publishing/intracellular-targets-made-druggable-tcr-antibodies-tcr-fusion-proteins-cell

Find all Pharma and Healthcare Reports at: https://www.marketresearchreports.com/pharma-healthcare

About Market Research Reports, Inc.
Market Research Reports® Inc. is world's largest store offering quality market research, SWOT analysis, competitive intelligence and industry reports. We help Fortune 500 to Start-Ups with the latest market research reports on global & regional markets which comprise key industries, leading market players, new products and latest industry analysis & trends.

Market Research Reports, Inc.
15192 Coastal Hwy,
Lewes, DE 19958, USA
Press Contact:
Mr. Sudeep Chakravarty
Director - Operations
USA: +1-302-703-9904
http://www.marketresearchreports.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Intracellular Targets Made Druggable by TCR-like Antibodies and Cell-Penetrating Biologics 2018; New Report Launched here

News-ID: 921734 • Views: 304

More Releases from Market Research Reports, Inc.

Big Data Driven Insights Helping Gaming, Media and Entertainment Companies in Bu …
Big Data in Global Media, Entertainment and Gaming Market 2021 is now available from MarketResearchReports.com Global Big Data market in Media, Entertainment and Gaming industry is poised to grow in the future mainly due to increase in the number of companies looking forward to incorporating useful customer insights based on their preference and behaviour and use it to produce content that will be more liked and consumed by the customers. The
Global Organized Retail Sectors Adopting Big Data at Faster Rate, Reveals New Ma …
Big Data in Global Retail Market 2021 is now available from MarketResearchReports.com Global Big Data market is on an upward swing. The industry is maturing and is estimated to do well over the next few years. In the retail sector, the big data market will be growing as well due to the high growth rate by the retail companies in their own sector. More and more people are using big data
Big Data Helps Global Telecos to Monetize Information and Prevent Customer Churn …
Big Data in Global Telecom Market 2021 is now available from MarketResearchReports.com Big Data is a vital strategic tool for telecom operators and MVNOs which can prevent revenue decline and identify the trend affecting markets globally. Big Data enables Telecom companies to leverage one of their strongest hidden assets, customer insights. Big Data technologies facilitates Telecom companies to capture, analyses and monetize large volumes of customer information and interaction data across
Global Smart Fabric Market to Grow at a CAGR of 18.88% till year 2021, Finds New …
Growth of worldwide population puts tremendous opportunities for the textile industry. This increase in population would in turn also significantly increase the use of technology and technological products and hence the demand for them is expected to increase exponentially. In the recent years, due to the increase in disposable income among the people of the developing countries, where the population growth rate is maximum, there is a trend of increasing

All 5 Releases


More Releases for TCR

Rail Systems Market Next Big Thing | Major Giants- Hitachi-Rail, TCR Rail System …
Global Rail Systems Market Data Survey Report 2015-2025 is latest research study released by HTF MI evaluating the market, highlighting opportunities, risk side analysis, and leveraged with strategic and tactical decision-making support. The study provides information on market trends and development, drivers, capacities, technologies, and on the changing investment structure of the Global Rail Systems Market. Some of the key players profiled in the study are Wabtec Corporation, Vermont Railway,
Rail Systems Market: Comprehensive study explores Huge Growth in Future| Key Pla …
HTF MI recently introduced new title on “Global Rail Systems Market Report 2018 ” from its database. The report provides study with in-depth overview, describing about the Product / Industry Scope and elaborates market outlook and status to 2025. The Report gives you competition analysis of top manufacturer with sales volume, price, revenue (Million USD) and market share, the top players including Wabtec Corporation, Vermont Railway, SPX FLOW Inc,
Rail Systems Market 2022: Wabtec Corporation, Vermont Railway, SPX FLOW Inc, Hit …
Worldwide Market Reports recently released “ Global Rail Systems Market Research Report 2017” that centers around the latest developing trends and technologies in the Global Rail Systems Market having Five Years of forecast period from 2017 to 2022 and considering Market status study from 2017 to 2022. During the research, noteworthy data was collected in order to shape the research document and make it a valuable resource for managers, industry executives
Recent Research On TCR & CAR Engineered T-Cell And NK Cell Therapeutics 2016: Co …
The report analyzes and presents an overview on "TCR & CAR Engineered T-Cell And NK Cell Therapeutics 2016: Convergence Of Technologies Opens Business Opportunities Beyond CD19 CARTs" worldwide. The report „TCR & CAR Engineered T-Cell and NK Cell Therapeutics 2016: Convergence of technologies opens business opportunities beyond CD19 CARTs“ describes and analyzes the status of the adoptive cell therapy industry as of August 2016. The report covers autologous and allogeneic engineered
TCR & CAR Engineered T-Cell And NK Cell Therapeutics 2016: Convergence Of Techno …
The report „TCR & CAR Engineered T-Cell and NK Cell Therapeutics 2016: Convergence of technologies opens business opportunities beyond CD19 CARTs“ describes and analyzes the status of the adoptive cell therapy industry as of August 2016. The report covers autologous and allogeneic engineered chimeric antigen receptor (CAR) and T-cell receptor (TCR) T-cell therapy candidates as well as natural killer (NK) cell and CAR engineered NK cells in research and development
TCR & CAR Engineered T-Cell And NK Cell Therapeutics 2016: Convergence Of Techno …
The report „TCR & CAR Engineered T-Cell and NK Cell Therapeutics 2016: Convergence of technologies opens business opportunities beyond CD19 CARTs“ describes and analyzes the status of the adoptive cell therapy industry as of August 2016. The report covers autologous and allogeneic engineered chimeric antigen receptor (CAR) and T-cell receptor (TCR) T-cell therapy candidates as well as natural killer (NK) cell and CAR engineered NK cells in research and development